anmelden
OMX Stockholm PI
1.117,80
PKT
-4,83
PKT
-0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 30.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.11.17 | Nokia Neutral | BNP PARIBAS | |
| 29.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 24.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.11.17 | AstraZeneca Reduce | HSBC | |
| 14.11.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Hold | S&P Capital IQ | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 08.11.17 | Nokia Neutral | BNP PARIBAS | |
| 08.11.17 | AstraZeneca buy | Citigroup Corp. | |
| 08.11.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 08.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 07.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | Nokia overweight | Barclays Capital | |
| 01.11.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 01.11.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.11.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Reduce | HSBC | |
| 01.11.17 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 31.10.17 | Nokia buy | Deutsche Bank AG | |
| 31.10.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 31.10.17 | ABB (Asea Brown Boveri) Conviction Buy | Goldman Sachs Group Inc. | |
| 30.10.17 | Nokia Outperform | Credit Suisse Group | |
| 30.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.10.17 | Nokia buy | S&P Capital IQ | |
| 27.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 27.10.17 | Nokia overweight | Morgan Stanley | |
| 27.10.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 27.10.17 | Nokia buy | Kepler Cheuvreux | |
| 27.10.17 | Nokia overweight | Barclays Capital |